Effects of Wenxin Keli on Cardiac Hypertrophy and Arrhythmia via Regulation of the CalciumCalmodulin Dependent Kinase II Signaling Pathway

Abstract EN

We investigated the effects of Wenxin Keli (WXKL) on the Calcium/Calmodulin dependent kinase II (CaMK II) signal transduction pathway with transverse aortic constriction (TAC) rats.

Echocardiographic measurements were obtained 3 and 9 weeks after the surgery.

Meanwhile, the action potentials (APDs) were recorded using the whole-cell patch clamp technique, and western blotting was used to assess components of the CaMK II signal transduction pathway.

At both 3 and 9 weeks after treatment, the fractional shortening (FS%) increased in the WXKL group compared with the TAC group.

The APD90 of the TAC group was longer than that of the Sham group and was markedly shortened by WXKL treatment.

Western blotting results showed that the protein expressions of CaMK II, phospholamban (PLB), and ryanodine receptor 2 (RYR2) were not statistically significant among the different groups at both treatment time points.

However, WXKL treatment decreased the protein level and phosphorylation of CaMK II (Thr-286) and increased the protein level and phosphorylation of PLB (Thr-17) and the phosphorylation of RYR2 (Ser-2814).

WXKL also decreased the accumulation of type III collagen fibers.

In conclusion, WXKL may improve cardiac function and inhibit the arrhythmia by regulating the CaMK II signal transduction pathway.